Rezo Therapeutics
Signal active
Organization
Contact Information
Overview
Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence. Rezo's proprietary platform can be used to treat a wide range of diseases. Rezo's initial focus is oncology, with plans to expand into other therapeutic areas through collaborations and partnerships.
About
Industries
Biotechnology, Product Research
Founded
2021
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Rezo Therapeutics headquartered in United States, North America, operates in the Biotechnology, Product Research sector. The company focuses on Biotechnology and has secured $624.0M in funding across 8 round(s). With a team of 1-10 employees, Rezo Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Rezo Therapeutics, raised $78.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
9
Lead Investors
0
Total Funding Amount
$78.0M
Details
1
Rezo Therapeutics has raised a total of $78.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 78.0M |
Investors
Rezo Therapeutics is funded by 15 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| UCSF Foundation Investment Company | - | FUNDING ROUND - UCSF Foundation Investment Company | 78.0M |
| Alexandria Venture Investments | - | FUNDING ROUND - Alexandria Venture Investments | 78.0M |
| Rezo Therapeutics | - | FUNDING ROUND - Rezo Therapeutics | 78.0M |
| Eli Lilly | - | FUNDING ROUND - Eli Lilly | 78.0M |
Recent Activity
There is no recent news or activity for this profile.